Research Determination

Att C Research Determination.pdf

[NCIPC] Performance Monitoring of CDC’s Comprehensive Suicide Prevention Program

Research Determination

OMB: 0920-1368

Document [pdf]
Download: pdf | pdf
Project Determination
Comprehensive Suicide Prevention Program
Project ID:

0900f3eb8231b703

Accession #:

NCIPC-ST-2/27/24-1b703

Project Contact:

Shamia Moore

Organization:

NCIPC/DIP/ASB/ST

Status:

Project In Progress

Intended Use:

Project Determination

Estimated Start Date:

09/30/20

Estimated Completion Date:

09/14/27

CDC/ATSDR HRPO/IRB Protocol#:
OMB Control#:

0920-1368

End of Human Research Date:

Description
Priority
Standard

Date Needed
11/08/24

CDC Priority Area for this Project
Not selected

Determination Start Date
02/27/24

Description
NCIPC’s Comprehensive Suicide Prevention (CSP) program is a non-research project that supports implementation and evaluation of a comprehensive public health
approach to suicide prevention. Eleven recipients were initially funded in 2020, which increased to 17 in 2022, and 24 in 202 3. These 24 CSP recipients provide

strong leadership as conveners of multi-sectoral partnerships; prioritize data to identify populations disproportionally affected and to better characterize risk factors
(e.g., relationship, job/financial, mental health problems) and protective factors (e.g., connectedness, hope, resilience) impacting suicide; leverage current
prevention practices and fill gaps by selecting multiple and complementary strategies with the best available evidence, using CDC’s Suicide Prevention Resource for
Action; rigorously evaluate the overall approach and individual activities; feed data back into the system for quality improvement and sustainability; and effectively
communicate results. As part of the CSP program, recipients collect program evaluation data for formative and process evaluation activities to assess and
iteratively inform their work. Recipients may use evaluation findings for programmatic planning and improvements, APR reporting and highlighting success with
CDC, and communication with partners. However, recipients do not report raw evaluation data to CDC, CDC is not involved in the collection of this data, nor does
CDC direct recipients to collect this formative and process evaluation data in specific ways. Recipients are also asked to report surveillance outcome data to CDC,
including suicide-related morbidity and mortality data. This project determination covers recipient-reported data, both non-required data collection activities
conducted by recipients for quality improvement, as well as required morbidity and mortality outcome evaluation data, both of which are reported to CDC in
aggregate.

IMS/CIO/Epi-Aid/Lab-Aid/Chemical Exposure Submission
No

IMS Activation Name
Not selected

Submitted through IMS clearance matrix
Not selected

Primary Scientific Priority
Not selected

Secondary Scientific Priority (s)
Not selected

Task Force Responsible
Not selected

CIO Emergency Response Name
Not selected

Epi-Aid Name
Not selected

Lab-Aid Name
Not selected

Assessment of Chemical Exposure Name
Not selected

Goals/Purpose

The purpose of this cooperative agreement is to implement and evaluate a comprehensive approach to suicide prevention, with a ttention to disproportionally
affected populations (e.g., veterans, tribal populations, rural communities, LGBTQ, homeless, other) that account for a significant proportion of the suicide burden
and have suicide rates greater than the general population in a jurisdiction(s) (e.g., state, city/county, tribe). Key outcomes include a 10% reduction in suicide
morbidity and mortality in the jurisdiction(s). This project collects information on suicide morbidity and mortality counts a nd rates to measure progress.
Additionally, the project collects performance monitoring (e.g., process evaluation) data via a web-based Partners’ Portal. Data are collected from 24 grantees and
are used to monitor progress toward program goals, identify technical assistance needs of recipients, and to provide accounta bility for funding to the Department
of Health and Human Services (HHS), the White House, Congress, and other sources, upon request. Because recipient evaluations are for assessment and
improvement of programs and are not generalizable, recipient activities are not considered research as defined by CFR and are subsequently not subject to IRB
review. In addition to the annual progress reports and performance measures submitted to CDC annually, recipients might also conduct additional internal
monitoring and evaluation to assess progress and to inform how programs are being planned and implemented. The specific data collection methods for their
program evaluation and quality improvement activities are not directed by the CDC nor is raw data collected by the CDC. The CDC does not provide prescriptive
requisites for this element of their work. While recipients do use some of their evaluation findings for reporting and highlighting program successes, they do not
submit any raw data to CDC.

Objective
Measurable outcomes are essential for determining the extent to which strategies and activities have reduced suicide morbidity and mortality in disproportionally
affected populations, as well as for continuous improvement of programming. Comprehensive Suicide Prevention recipients develop and implement a
comprehensive suicide prevention plan and measure both process measures associated with implementation of selected strategies as well as their impact over the
project period on longer term behavior and risk and protective factor outcomes associated with identified populations. Recipients are required to measure the longterm impact of the comprehensive approach on morbidity and mortality outcomes. This project also collects aggregate performance monitoring data (e.g., process
measures) via a web-based Partners’ Portal on an annual schedule. Recipients can conduct additional evaluation activities related to continuously assessing
progress to inform how programs are being planned and implemented.

Does your project measure health disparities among populations/groups experiencing social, economic, geographic, and/or
environmental disadvantages?
Yes

Does your project investigate underlying contributors to health inequities among populations/groups experiencing social,
economic, geographic, and/or environmental disadvantages?
No

Does your project propose, implement, or evaluate an action to move towards eliminating health inequities?
Yes

Activities or Tasks
New Collection of Information, Data, or Biospecimens; Secondary Data or Specimen Analysis; Programmatic Work

Target Population to be Included/Represented
General US Population

Tags/Keywords
Suicide; Suicide, Attempted; Suicidal Ideation

CDC's Role
Activity originated and designed by CDC staff, or conducted at the specific request of CDC, or CDC staff will approve study design and data collection as a condition
of any funding provided; CDC employees or agents will obtain or use anonymous or unlinked data or biological specimens; CDC employees will provide substantial
technical assistance or oversight; CDC is NOT a recipient or provider of private data, specimens, materials or services; CDC is providing funding

Method Categories
Secondary Data Analysis; Surveillance Support; Technical Assistance

Methods
Comprehensive Suicide Prevention recipients will develop and implement a comprehensive suicide prevention plan and measure both process measures associated
with implementation of selected strategies as well as their impact over the project period on longer term behavior and risk and protective factor outcomes
associated with identified populations. Recipients will also be required to measure the long-term impact of the comprehensive approach on morbidity and mortality
outcomes. This project will collect performance monitoring data via a web-based Partners’ Portal on an annual schedule, and CDC will report aggregate results.
Recipients are required to both implement and evaluate their activities to assess implementation and progress toward outcomes. Recipients program evaluation
activities may include formative, process, and outcome evaluation to inform activities, engage in continuous quality improvement, and assess progress toward
program outcomes. While some of the evaluation findings are used for APR reporting and highlighting successful work with CDC, process evaluation data is largely
used internally by CSP recipients to redirect activities, inform changes in project strategies, and to communicate findings w ith their local partners. The specific data
collection methods for their quality improvement evaluation activities are not directed by the CDC nor is this data collected by the CDC. The CDC does not provide
prescriptive requisites for this element of their work.

Collection of Info, Data, or Bio specimens
This project collects performance monitoring data from 24 recipients of Comprehensive Suicide funds via a web-based Partners’ Portal on an annual schedule, and
CDC will report aggregate results. No personally identifiable information will be collected. OMB number 0920-1368 (exp. date 9/30/2025) covers this project and
amendments have been submitted to account for newly added recipients over time. Recipients also use varying methods to collec t and use data for quality
improvement purposes. The CDC does not provide requirements for specific data collection methods, nor does CDC receive this raw data. Some examples of the
ways in which recipients collect their own internal program evaluation data include pre- and post-training surveys, focus groups, and reviewing external
programmatic data provided by partners.

Expected Use of Findings/Results and their impact
Results are collected from 24 grantees and will be used to monitor progress toward program goals, identify technical assistance needs of recipients, and to provide
accountability for funding to the Department of Health and Human Services (HHS), the White House, Congress, and other sources , upon request. Findings will be
distributed through peer-reviewed publications and presentations, as well. Recipients use the internal program evaluation data they collect to inform the
implementation of programs and strategies. Program evaluation data from these activities is largely used internally by CSP recipients to redirect activities, inform
changes in project strategies, and to communicate findings with their local partners. While recipients do use some of their evaluation findings for reporting and
highlighting program successes, they do not submit any raw data to CDC.

Could Individuals potentially be identified based on Information Collected?
No

Funding
Funding Type

Funding Title

Funding #

Original Fiscal
Year

# of Years
of Award

Budget
Amount

CDC Cooperative

Comprehensive Suicide Prevention

CDC-RFA-CE20-2001

2020

5

9532139.00

CDC Cooperative

Expansion of Comprehensive Suicide

CDC-RFA-CE22-2204

2022

5

11820655.00

Agreement

Prevention Across the U.S.

Agreement

HSC Review
HSC Attributes
Program Evaluation
Yes

Regulation and Policy
Do you anticipate this project will require review by a CDC IRB or HRPO?
No

Will you be working with an outside Organization or Institution? Yes

Institutions
Institution

FWA #

FWA Exp.
Date

California Department of Health

Funding
Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Vermont Department of Health

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

The University of Pittsburgh

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

North Carolina Department of Health and Human Services

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Florida Department of Health

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Georgia Department of Public Health

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Arkansas Dept of Hlth

FWA00002961

03/25/27

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Bexar Co Hosp District

FWA00003754

07/23/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Colorado Department of Public Health & Environment

FWA00003044

01/22/29

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Connecticut Department of Public Health

FWA00026243

07/11/27

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Illinois Department of Public Health

FWA00002005

07/02/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Louisiana Department of Health

FWA00026681

02/12/29

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Funding
Restriction
Amount

Massachusetts Department of Public Health

FWA00000786

08/26/27

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Michigan Department of Health and Human Services

FWA00007331

04/09/29

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Ohio Dept of Hlth

FWA00001963

12/20/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Oregon Health Authority - Public Hlth Division

FWA00000520

10/04/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Puerto Rico Dept Hlth

FWA00006333

02/17/22

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Research Foundation Mental Hygiene Inc. & NY State Dept Mental Hygiene

FWA00006105

10/11/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Rhode Island Department of Health

FWA00006141

09/13/27

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

State of Maine Department of Health and Human Services

FWA00016239

01/22/30

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

Tennessee Department of Health

FWA00000379

01/18/27

Comprehensive Suicide Prevention
- CDC-RFA-CE20-2001

U Nebraska-Lincoln

FWA00002258

11/25/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

U North Dakota

FWA00000376

05/01/29

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Wisconsin Dept of Health Services

FWA00002517

09/14/28

Expansion of Comprehensive
Suicide Prevention Across the U.S.
- CDC-RFA-CE22-2204

Institution
California Department of Health
Vermont Department of Health
The University of Pittsburgh
North Carolina Department of Health
and Human Services
Florida Department of Health
Georgia Department of Public Health
Arkansas Dept of Hlth
Bexar Co Hosp District
Colorado Department of Public Health
& Environment
Connecticut Department of Public
Health
Illinois Department of Public Health
Louisiana Department of Health
Massachusetts Department of Public
Health
Michigan Department of Health and
Human Services
Ohio Dept of Hlth
Oregon Health Authority - Public Hlth
Division
Puerto Rico Dept Hlth
Research Foundation Mental Hygiene
Inc. & NY State Dept Mental Hygiene
Rhode Island Department of Health
State of Maine Department of Health
and Human Services
Tennessee Department of Health
U Nebraska-Lincoln
U North Dakota

Funding Restriction Percentage

Funding Restriction Reason

Funding Restriction has been
lifted

Wisconsin Dept of Health Services

Institution

Institution Role(s)

California Department of

Receiving Direct HHS Support

Health

(Prime Awardee)

Vermont Department of Health

Receiving Direct HHS Support
(Prime Awardee)

The University of Pittsburgh

Receiving Direct HHS Support
(Prime Awardee)

North Carolina Department of

Receiving Direct HHS Support

Health and Human Services

(Prime Awardee)

Florida Department of Health

Receiving Direct HHS Support
(Prime Awardee)

Georgia Department of Public

Receiving Direct HHS Support

Health

(Prime Awardee)

Arkansas Dept of Hlth

Receiving Direct HHS Support
(Prime Awardee)

Bexar Co Hosp District

Receiving Direct HHS Support
(Prime Awardee)

Colorado Department of Public

Receiving Direct HHS Support

Health & Environment

(Prime Awardee)

Connecticut Department of

Receiving Direct HHS Support

Public Health

(Prime Awardee)

Illinois Department of Public

Receiving Direct HHS Support

Health

(Prime Awardee)

Louisiana Department of

Receiving Direct HHS Support

Health

(Prime Awardee)

Massachusetts Department of

Receiving Direct HHS Support

Public Health

(Prime Awardee)

Michigan Department of Health

Receiving Direct HHS Support

and Human Services

(Prime Awardee)

Ohio Dept of Hlth

Obtaining Consent

Oregon Health Authority -

Receiving Direct HHS Support

Public Hlth Division

(Prime Awardee)

Institution Project Title

Institution Project
Tracking #

Prime Institution

Puerto Rico Dept Hlth

Receiving Direct HHS Support
(Prime Awardee)

Research Foundation Mental

Receiving Direct HHS Support

Hygiene Inc. & NY State Dept

(Prime Awardee)

Mental Hygiene
Rhode Island Department of

Receiving Direct HHS Support

Health

(Prime Awardee)

State of Maine Department of

Receiving Direct HHS Support

Health and Human Services

(Prime Awardee)

Tennessee Department of

Receiving Direct HHS Support

Health

(Prime Awardee)

U Nebraska-Lincoln

Receiving Direct HHS Support
(Prime Awardee)

U North Dakota

Receiving Direct HHS Support
(Prime Awardee)

Wisconsin Dept of Health

Receiving Direct HHS Support

Services

(Prime Awardee)

Institution

Regulatory Coverage

California Department of Health

IRB Review is Not Required

Vermont Department of Health

IRB Review is Not Required

The University of Pittsburgh

IRB Review is Not Required

North Carolina Department of Health and Human

IRB Review is Not Required

Services
Florida Department of Health

IRB Review is Not Required

Georgia Department of Public Health

IRB Review is Not Required

Arkansas Dept of Hlth

IRB Review is Not Required

Bexar Co Hosp District

IRB Review is Not Required

Colorado Department of Public Health &

IRB Review is Not Required

Environment
Connecticut Department of Public Health

IRB Review is Not Required

Illinois Department of Public Health

IRB Review is Not Required

Louisiana Department of Health

IRB Review is Not Required

Massachusetts Department of Public Health

IRB Review is Not Required

Michigan Department of Health and Human Services

IRB Review is Not Required

Ohio Dept of Hlth

IRB Review is Not Required

Oregon Health Authority - Public Hlth Division

IRB Review is Not Required

Puerto Rico Dept Hlth

IRB Review is Not Required

Research Foundation Mental Hygiene Inc. & NY State

IRB Review is Not Required

Dept Mental Hygiene
Rhode Island Department of Health

IRB Review is Not Required

State of Maine Department of Health and Human

IRB Review is Not Required

Services
Tennessee Department of Health

IRB Review is Not Required

U Nebraska-Lincoln

IRB Review is Not Required

U North Dakota

IRB Review is Not Required

Wisconsin Dept of Health Services

IRB Review is Not Required

IRB Review Status

Institution

Registered IRB

IRB Registration Exp. Date

Louisiana Department of Health IRB

02/23/27

California Department of Health
Vermont Department of Health
The University of Pittsburgh
North Carolina Department of Health
and Human Services
Florida Department of Health
Georgia Department of Public Health
Arkansas Dept of Hlth
Bexar Co Hosp District
Colorado Department of Public Health
& Environment
Connecticut Department of Public
Health
Illinois Department of Public Health
Louisiana Department of Health

#2
Massachusetts Department of Public

Massachusetts Dept Public Hlth Human

Health

Research Review Committee IRB #1

05/26/26

Michigan Department of Health and
Human Services
Ohio Dept of Hlth

Ohio Dept of Hlth IRB #1

01/10/27

Oregon Health Authority - Public Hlth

DHS-Health Svces/Multnomah Co

06/15/26

Division

Public Hlth IRB #1

Puerto Rico Dept Hlth
Research Foundation Mental Hygiene
Inc. & NY State Dept Mental Hygiene
Rhode Island Department of Health

RHODE ISLAND STE DEPT
#1

State of Maine Department of Health
and Human Services
Tennessee Department of Health
U Nebraska-Lincoln

HLTH IRB

08/17/25

IRB Approval Status

U North Dakota
Wisconsin Dept of Health Services

Institution
California Department of Health
Vermont Department of Health
The University of Pittsburgh
North Carolina Department of Health
and Human Services
Florida Department of Health
Georgia Department of Public Health
Arkansas Dept of Hlth
Bexar Co Hosp District
Colorado Department of Public Health
& Environment
Connecticut Department of Public
Health
Illinois Department of Public Health
Louisiana Department of Health
Massachusetts Department of Public
Health
Michigan Department of Health and
Human Services
Ohio Dept of Hlth
Oregon Health Authority - Public Hlth
Division
Puerto Rico Dept Hlth
Research Foundation Mental Hygiene
Inc. & NY State Dept Mental Hygiene
Rhode Island Department of Health
State of Maine Department of Health
and Human Services
Tennessee Department of Health
U Nebraska-Lincoln
U North Dakota
Wisconsin Dept of Health Services

IRB Approval Date

IRB Approval Exp. Date

Relying Institution IRB

Staff
Staff
Member

SIQT Exp.
Date

Citi
Biomedical
Exp. Date

Citi Social
and
Behavioral
Exp. Date

AaronGrober

07/24/2026

05/08/2020

07/12/2021

Citi Good
Clinical
Exp. Date

Citi Good
Laboratory
Practice
Exp. Date

Staff Role

Email

Phone #

Organizatio
n/
Institution

Project Officer

xih7@cdc.

770-488-0787

APPLIED

gov

SCIENCE
BRANCH

AbhilashPhilipo

07/18/2026

11/14/2027

Project Officer

se

xkh6@cdc.

770-488-3835

gov

APPLIED
SCIENCE
BRANCH

AlexCharleston

06/26/2026

10/17/2027

Project Officer

aac4@cdc.

770-488-3183

gov

APPLIED
SCIENCE
BRANCH

AlisonCammack

AmyGallagher
DeborahStone

01/02/2027

12/06/2027

05/25/2026
12/16/2025

10/15/2027

Technical

umw5@cd

Monitor

c.gov

Technical

tzo0@cdc.

Monitor

gov

Program Lead

zaf9@cdc.

770-488-2880

SUICIDE TEAM

770-488-2091

EVALUATION
TEAM

770-488-3942

gov

DIVISION OF
INJURY
PREVENTION

JingWang
KatherineMoran

06/26/2026
10/12/2026

05/31/2022

10/10/2027
04/17/2026

Technical

zrr4@cdc.

Monitor

gov

Technical

rtq5@cdc.

Monitor

gov

770-488-1193

SUICIDE TEAM

-

APPLIED

-

SCIENCE
BRANCH

LaurenBeagle

08/02/2026

10/03/2027

Technical

ghs0@cdc.

Monitor

gov

248-884-7721

STATISTICS,
PROGRAMMIN
G AND
ECONOMICS
BRANCH

Staff
Staff
Member

SIQT Exp.
Date

RobinLee

12/15/2025

Citi
Biomedical
Exp. Date

Citi Social
and
Behavioral
Exp. Date

Citi Good
Clinical
Exp. Date

12/16/2027

Citi Good
Laboratory
Practice
Exp. Date

Staff Role

Email

Phone #

Organizatio
n/
Institution

Program Lead

rpl5@cdc.

770-488-3811

APPLIED

gov

SCIENCE
BRANCH

SadeCollins

10/12/2026

Project Officer

qut5@cdc.

404-498-4444

SUICIDE TEAM

404-639-4170

SUICIDE TEAM

404-718-7447

EVALUATION

gov
ShamiaMoore
SusanneMcGhe

10/12/2025
12/19/2026

11/12/2027
06/09/2025

e
VincentDoan

07/05/2026

Technical

sey3@cdc.

Monitor

gov

Technical

otb4@cdc.

Monitor

gov

Project Officer

skn9@cdc.

TEAM
404-498-0548

SUICIDE TEAM

404-498-4050

APPLIED

gov
WilliamBaker

11/17/2025

11/18/2027

Technical

qoo3@cdc

Monitor

.gov

SCIENCE
BRANCH

WilliamHolman

08/28/2026

Project Officer

uap8@cdc

770-601-0738

.gov

DATA
ANALYTICS
BRANCH

WojciechKaczk

08/02/2026

03/25/2025

owski

Technical

ppu4@cdc

Monitor

.gov

404-718-2221

APPLIED
SCIENCE
BRANCH

ZadiaValdez

08/31/2026

Project Officer

pwl5@cdc.
gov

DMP
Proposed Data Collection Start Date

09/30/20

Proposed Data Collection End Date

09/14/27

Proposed Public Access Level

Non-Public

770-488-4562

SUICIDE TEAM

Reason for not Releasing the Data

CIO conducting this project does not fund or own the data and is not responsible for making it
available

Public Access justification

CDC is collecting data management plans from all awardees. They will be responsible for making
data available upon request, in accordance with their state policies.

How Access Will Be Provided for Data

Cooperative agreement awardees will make data available in accordance with their state policies
and as specified in their individual data management plans.

Plans for archival and long-term preservation of

Cooperative agreement awardees will store data in accordance with their state policies and as

the data

specified in their individual data management plans.

Spatiality (Geographic Location)
Country

State/Province

United States

Louisiana

United States

Connecticut

United States

Colorado

United States

California

United States

Arkansas

United States

Nebraska

United States

Georgia

United States

New York

United States

Oregon

United States

Wisconsin

United States

North Dakota

United States

Florida

United States

Vermont

United States

Tennessee

United States

Pennsylvania

United States

North Carolina

United States

Michigan

United States

Massachusetts

United States

Maine

United States

Texas

United States

Illinois

United States

Ohio

Puerto Rico
United States

Rhode Island

County/Region

Bexar County

Determinations
Determination

Justification

Completed

Entered By & Role

HSC:

Not Research / Other

11/07/24

Halstead_Mary (ygg9) CIO HSC

11/08/24

Halstead_Mary (ygg9) OMB / PRA

11/08/24

Zirger_Jeffrey (wtj5) ICRO Reviewer

Does NOT Require HRPO
Review

45 CFR 46.102(l)

Program Evaluation
Quality Assurance / Improvement
PRA:
PRA Applies
ICRO:

OMB Approval date: 06/13/23

PRA Applies

OMB Expiration date: 06/30/26


File Typeapplication/pdf
AuthorMoore, Shamia (CDC/NCIPC/DIP)
File Modified2025-06-20
File Created2025-02-10

© 2025 OMB.report | Privacy Policy